Herbert M. Pinedo

36.1k citations

571 papers · 29.8k indexed · 6 hit papers · h-index 91

Oncology top 0.02%
- Colorectal Cancer Treatments and Studies 91
- Cancer Treatment and Pharmacology 89
- Drug Transport and Resistance Mechanisms 57
- Cancer-related Molecular Pathways 28
Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 38
Immunology top 0.5%
- Immunotherapy and Immune Responses 29
Molecular Biology top 0.2%
- Cancer therapeutics and mechanisms 77
- Biochemical and Molecular Research 46
Hematology top 0.5%

Co-authors: Godefridus J. Peters Giuseppe Giaccone Rik J. Scheper Henk M.W. Verheul Epie Boven Jan B. Vermorken J. Lankelma Jaap Verweij
Cited by: Oncology Cancer Research Immunology
Partner nations: Netherlands United States Belgium

In The Last Decade

Herbert M. Pinedo

567 papers receiving 28.8k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2003 Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2001 Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
1995 The drug resistance-related protein LRP is the human major vault protein
1994 The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
1990 Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
1988 Fluorouracil: biochemistry and pharmacology.

Peers

Countries citing papers authored by Herbert M. Pinedo

Since Specialization

Citations

This map shows the geographic impact of Herbert M. Pinedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert M. Pinedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert M. Pinedo more than expected).

Fields of papers citing papers by Herbert M. Pinedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert M. Pinedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert M. Pinedo. The network helps show where Herbert M. Pinedo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Herbert M. Pinedo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Herbert M. Pinedo Line = papers co-authored together Herbert M. Pinedo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer Vincent A. de Weger,Annelies W. Turksma,Quirinus J.M. Voorham,Zelda Euler,Herman Bril,Alfons J. van den Eertwegh,Elisabeth Bloemena,Herbert M. Pinedo,Jan B. Vermorken,Harm van Tinteren,Gerrit A. Meijer,Erik Hooijberg	2011	54
2	A phase I-II clinical trial with JX-594, a targeted and GM-CSF-armed oncolytic poxvirus, by intratumoral injection in patients with liver tumors Byeong-Ho Park,Tae-Ho Hwang,Seung-Geon Kim,Byong-Geon Rhee,Young-Joo Ahn,Hyuk-Chan Kwon,Seung-Yong Oh,Sang‐Young Han,Kelly Speth,Anne Crompton,Patrick W. Trown,M. Jason Hatfield,Ta‐Chiang Liu,Herbert M. Pinedo,John C. Bell,David H. Kirn	2007	5
3	Early Apoptosis Largely Accounts for Functional Impairment of CD34 ⁺ Cells in Frozen-Thawed Stem Cell Grafts Fransien de Boer,Angelika M. Dräger,Herbert M. Pinedo,Floortje L. Kessler,M. Monnee-van Muijen,G W D Weijers,Guus Westra,Elsken van der Wall,Tanja Netelenbos,Jan W. Oberink,Peter C. Huijgens,Gerrit Jan Schuurhuis	2002	52
4	Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesisbreakdown → Reinhard Bos,Haining Zhong,Colleen F. Hanrahan,Ellen C.M. Mommers,Gregg L. Semenza,Herbert M. Pinedo,Martin D. Abeloff,Jonathan W. Simons,P. J. van Diest,Elsken van der Wall	2001	508
5	The hidden treasures of the primary tumor: Extended neoadjuvant chemotherapy plus GM-CSF in locally advanced cancer Herbert M. Pinedo,Jan Buter	2000	2
6	Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates Harold H.J. Backus,Herbert M. Pinedo,D. Wouters,C.M. Kuiper,Gerrit Jansen,C.J. van Groeningen,Godefridus J. Peters	2000	1
7	CPT‐11 in human colon‐cancer cell lines and xenografts: Characterization of cellular sensitivity determinants Willy J.M. Jansen,Bas Zwart,Saskia Hulscher,Giuseppe Giaccone,Herbert M. Pinedo,E. Boven	1997	3
8	CPT-11 in human colon-cancer cell lines and xenografts: Characterization of cellular sensitivity determinants Willy J.M. Jansen,Bas Zwart,Saskia Hulscher,Giuseppe Giaccone,Herbert M. Pinedo,E. Boven	1997	103
9	Expression of drug resistance proteins in breast cancer, in relation to chemotherapy Sabine C. Linn,Herbert M. Pinedo,J van Ark-Otte,Paul van der Valk,Klaas Hoekman,Aafke H. Honkoop,Jan B. Vermorken,Giuseppe Giaccone	1997	7
10	A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile. N Feller,Klaas Hoekman,Catharina M. Kuiper,Sabine C. Linn,Henk M.W. Verheul,B.G. Wolthers,C. Popp‐Snijders,Herbert M. Pinedo	1997	9
11	Oxford textbook of oncology Michael Peckham,Herbert M. Pinedo,Umberto Veronesi	1996	247
12	A Monoclonal Antibody against Human β-Glucuronidase for Application in Antibody-Directed Enzyme Prodrug Therapy Hidde J. Haisma,MONIQUE VAN MUIJEN,George L. Scheffer,Rik J. Scheper,Herbert M. Pinedo,Epie Boven	1995	10
13	Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates P. E. Pizao,D.M. Lyaruu,Godefridus J. Peters,J van Ark-Otte,Benjamin Winograd,Giuseppe Giaccone,Herbert M. Pinedo	1992	29
14	Multicenter Phase II Study of Spiroplatin Bea C. Tanis,Jan B. Vermorken,W.W. ten Bokkel Huinink,Allan T. van Oosterom,Ted A.W. Splinter,Ko J. Vendrik,Dirk Th. Sleijfer,Maria E.L. Van der Burgs,Erie Van der Putten,Herbert M. Pinedo	1992	9
15	A randomized trial comparing the effect of epirubicin and doxorubicin in soft tissue sarcoma Herbert M. Pinedo,H.T. Mouridsen,R. Somers,A. Santor,Y. H. Mulder,V. Blanwell,A.T. van Oosterom,R. Sylvester,D.V. Thomas	1987	2
16	Cancer chemotherapy and biological response modifiers annual Herbert M. Pinedo,Dario Livio Longo,B A Chabner	1987	221
17	Metabolic activation of the antitumor agent vp 16 213 J.M.S. van Maanen,P.R. Kootstra,J. Broersen,M.V.M. Lafleur,J. Retèl,E. Kriek,Herbert M. Pinedo	1986	4
18	The cancer pharmacology annual B A Chabner,Herbert M. Pinedo	1984	7
19	Gastrointestinal toxicity of cis-diamminedichloroplatinum (II). Personal observations J. B. Vermorken,Herbert M. Pinedo	1982	38
20	EORTC protocol for therapy of metastatic soft tissue sarcomas, a randomized trial Herbert M. Pinedo,C. P. J. Vendrik,M. Staquet,Y. Kenis,Richard Sylvester	1977	3

About Herbert M. Pinedo

Herbert M. Pinedo is a scholar working on Oncology, Cancer Research and Hematology, having authored 571 papers that have together received 29.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (91 papers), Cancer Treatment and Pharmacology (89 papers), Cancer therapeutics and mechanisms (77 papers), Drug Transport and Resistance Mechanisms (57 papers), Biochemical and Molecular Research (46 papers), Cancer, Hypoxia, and Metabolism (38 papers), Immunotherapy and Immune Responses (29 papers) and Cancer-related Molecular Pathways (28 papers). The work is most often cited by research in Oncology (15.8k citations), Cancer Research (3.5k citations) and Immunology (3.8k citations). Herbert M. Pinedo has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Godefridus J. Peters, Giuseppe Giaccone, Rik J. Scheper, Henk M.W. Verheul, Epie Boven, Jan B. Vermorken, J. Lankelma, Jaap Verweij, Klaas Hoekman and C.J. van Groeningen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact